Estimated glomerular filtration rate as a tool for early identification of patients with insufficient exposure to beta-lactam antibiotics in intensive care units

References

• Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323–2329. doi: 10.1001/jama.2009.1754.
   PubMed Web of Science ®Google Scholar
• Vincent JL, Sakr Y, Singer M, et al. Prevalence and outcomes of infection Among patients in intensive care units in 2017. JAMA. 2020;323(15):1478–1487. doi: 10.1001/jama.2020.2717.
   PubMed Web of Science ®Google Scholar
• Evans L, Rhodes A, Alhazzani W, et al. Executive summary: surviving sepsis campaign: international guidelines for the management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):1974–1982. doi: 10.1097/CCM.0000000000005357.
   PubMed Web of Science ®Google Scholar
• Abdul-Aziz MH, Alffenaar JC, Bassetti M, et al. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper. Intensive Care Med. 2020;46(6):1127–1153. doi: 10.1007/s00134-020-06050-1.
   PubMed Web of Science ®Google Scholar
• McKinnon PS, Paladino JA, Schentag JJ. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T > MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. Int J Antimicrob Agents. 2008;31(4):345–351. doi: 10.1016/j.ijantimicag.2007.12.009.
   PubMed Web of Science ®Google Scholar
• Roberts JA, Paul SK, Akova M, et al. DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis. 2014;58(8):1072–1083. doi: 10.1093/cid/ciu027.
   PubMed Web of Science ®Google Scholar
• Swedish Strategic Programme against antibiotic resistance (STRAMA) [Internet]. STRAMA Nationell – Behandlingsrekommendationer i app [Database application]. STRAMA Nationell; 2022; [updated 2021 Sep 21]. Available from: https://strama-nationell.infosynk.se/.
   Google Scholar
• Rationale documents. 2022; [cited 2022 Jan 01]. Available from: https://www.eucast.org/publications-and-documents/rd.
   Google Scholar
• FASS. https://www.fass.se/LIF/startpage. Läkemedelsindustriföreningen (LiF); 2023; FASS – Summary of Product Characteristics.
   Google Scholar
• Woksepp H, Hällgren A, Borgström S, et al. High target attainment for beta-lactam antibiotics in intensive care unit patients when actual minimum inhibitory concentrations are applied. Eur J Clin Microbiol Infect Dis. 2017;36(3):553–563. doi: 10.1007/s10096-016-2832-4.
   PubMed Web of Science ®Google Scholar
• Smekal AK, Furebring M, Eliasson E, et al. Low attainment to PK/PD-targets for beta-lactams in a multi-center study on the first 72 h of treatment in ICU patients. Sci Rep. 2022;12(1):21891. doi: 10.1038/s41598-022-25967-9.
   PubMedGoogle Scholar
• Zander J, Döbbeler G, Nagel D, et al. Piperacillin concentration in relation to therapeutic range in critically ill patients–a prospective observational study. Crit Care. 2016;20(1):79. doi: 10.1186/s13054-016-1255-z.
   PubMedGoogle Scholar
• Sime FB, Roberts MS, Peake SL, et al. Does beta-lactam pharmacokinetic variability in critically ill patients justify therapeutic drug monitoring? A systematic review. Ann Intensive Care. 2012;2(1):35. doi: 10.1186/2110-5820-2-35.
   PubMed Web of Science ®Google Scholar
• Boidin C, Moshiri P, Dahyot-Fizelier C, et al. Pharmacokinetic variability of beta-lactams in critically ill patients: a narrative review. Anaesth Crit Care Pain Med. 2020;39(1):87–109. doi: 10.1016/j.accpm.2019.07.016.
   PubMed Web of Science ®Google Scholar
• De Gaetano AC,G, Gram Pedersen M, Panunzi S, et al. Modeling serum creatinine in septic ICU patients. Cardiovasc Eng. 2004;4(2):173–180. doi: 10.1023/B:CARE.0000031546.79563.bd.
   Google Scholar
• Guilhaumou R, Benaboud S, Bennis Y, et al. Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French society of pharmacology and therapeutics (societe francaise de pharmacologie et Therapeutique-SFPT) and the French society of anaesthesia and intensive care medicine (Societe Francaise d‘Anesthesie et Reanimation-SFAR). Crit Care. 2019;23(1):104. doi: 10.1186/s13054-019-2378-9.
   PubMedGoogle Scholar
• Kollef MH, Shorr AF, Bassetti M, et al. Timing of antibiotic therapy in the ICU. Crit Care. 2021;25(1):360. doi: 10.1186/s13054-021-03787-z.
   PubMed Web of Science ®Google Scholar
• Nauclér P, Huttner A, van Werkhoven CH, et al. Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship. Clin Microbiol Infect. 2021;27(2):175–181. doi: 10.1016/j.cmi.2020.02.032.
   PubMed Web of Science ®Google Scholar
• Abdulla A, Ewoldt TMJ, Purmer IM, et al. A narrative review of predictors for beta-lactam antibiotic exposure during empirical treatment in critically ill patients. Expert Opin Drug Metab Toxicol. 2021;17(4):359–368. doi: 10.1080/17425255.2021.1879049.
   PubMed Web of Science ®Google Scholar
• Udy AA, Roberts JA, Shorr AF, et al. Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients. Crit Care. 2013;17(1):R35. doi: 10.1186/cc12544.
   PubMed Web of Science ®Google Scholar
• Peerapornratana S, Manrique-Caballero CL, Gomez H, et al. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 2019;96(5):1083–1099. doi: 10.1016/j.kint.2019.05.026.
   PubMed Web of Science ®Google Scholar
• Wu CC, Tai CH, Liao WY, et al. Augmented renal clearance is associated with inadequate antibiotic pharmacokinetic/pharmacodynamic target in Asian ICU population: a prospective observational study. Infect Drug Resist. 2019;12:2531–2541. doi: 10.2147/IDR.S213183.
   PubMed Web of Science ®Google Scholar
• Ruiz S, Minville V, Asehnoune K, et al. Screening of patients with augmented renal clearance in ICU: taking into account the CKD-EPI equation, the age, and the cause of admission. Ann Intensive Care. 2015;5(1):49. doi: 10.1186/s13613-015-0090-8.
   PubMedGoogle Scholar
• Campassi ML, Gonzalez MC, Masevicius FD, et al. Augmented renal clearance in critically ill patients: incidence, associated factors and effects on vancomycin treatment]. Rev Bras Ter Intensiva. 2014;26(1):13–20. doi: 10.5935/0103-507x.20140003.
   PubMedGoogle Scholar
• Cook AM, Hatton-Kolpek J. Augmented renal clearance. Pharmacotherapy. 2019;39(3):346–354. doi: 10.1002/phar.2231.
   PubMed Web of Science ®Google Scholar
• Sangla F, Marti PE, Verissimo T, et al. Measured and estimated glomerular filtration rate in the ICU: a prospective study. Crit Care Med. 2020;48(12):e1232–e41. doi: 10.1097/CCM.0000000000004650.
   PubMed Web of Science ®Google Scholar
• Trevisani F, Di Marco F, Capitanio U, et al. Renal function assessment gap in clinical practice: an awkward truth. Kidney Blood Press Res. 2020;45(2):166–179. doi: 10.1159/000504649.
   PubMed Web of Science ®Google Scholar
• Bragadottir G, Redfors B, Ricksten SE. Assessing glomerular filtration rate (GFR) in critically ill patients with acute kidney injury–true GFR versus urinary creatinine clearance and estimating equations. Crit Care. 2013;17(3):R108. doi: 10.1186/cc12777.
   PubMed Web of Science ®Google Scholar
• Inker LA, Eneanya ND, Coresh J, et al. New creatinine and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737–1749. doi: 10.1056/NEJMoa2102953.
   PubMed Web of Science ®Google Scholar
• Björk J, Grubb A, Sterner G, et al. Revised equations for estimating glomerular filtration rate based on the Lund-Malmo study cohort. Scand J Clin Lab Invest. 2011;71(3):232–239. doi: 10.3109/00365513.2011.557086.
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Greene T, et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53(4):766–772. doi: 10.1373/clinchem.2006.077180.
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi: 10.1159/000180580.
   PubMed Web of Science ®Google Scholar
• Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition. 1989;5(5):303–311.
   PubMed Web of Science ®Google Scholar
• Clinical breakpoints. 2022; [cited 2022 Jan 1]. Available from: https://www.eucast.org/clinical_breakpoints.
   Google Scholar
• Wong G, Briscoe S, Adnan S, et al. Protein binding of beta-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations? Antimicrob Agents Chemother. 2013;57(12):6165–6170. doi: 10.1128/AAC.00951-13.
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Roberts JA, Paterson DL, et al. Pharmacokinetic evaluation of piperacillin-tazobactam. Expert Opin Drug Metab Toxicol. 2010;6(8):1017–1031. doi: 10.1517/17425255.2010.506187.
   PubMed Web of Science ®Google Scholar
• Patel BM, Paratz J, See NC, et al. Therapeutic drug monitoring of beta-lactam antibiotics in burns patients – a one-year prospective study. Ther Drug Monit. 2012;34(2):160–164. doi: 10.1097/FTD.0b013e31824981a6.
   PubMed Web of Science ®Google Scholar
• MacDonald PL, Gardner RC. Type I error rate comparisons of post hoc procedures for I x J Chi-Square tables. Educ Psychol Meas. 2000;60(5):735–754. doi: 10.1177/00131640021970871.
   Web of Science ®Google Scholar
• Imani S, Buscher H, Day R, et al. An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric beta-lactam therapy. Eur J Clin Microbiol Infect Dis. 2018;37(11):2171–2175. doi: 10.1007/s10096-018-3357-9.
   PubMed Web of Science ®Google Scholar
• Alobaid AS, Brinkmann A, Frey OR, et al. What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients? J Antimicrob Chemother. 2016;71(3):696–702. doi: 10.1093/jac/dkv412.
   PubMed Web of Science ®Google Scholar
• Roelofsen EE, Abdulla A, Muller AE, et al. Dose optimization of cefotaxime as pre-emptive treatment in critically ill adult patients: a population pharmacokinetic study. Br J Clin Pharmacol. 2023;89(2):705–713. doi: 10.1111/bcp.15487.
   PubMed Web of Science ®Google Scholar
• Petersson J, Giske CG, Eliasson E. Standard dosing of piperacillin and meropenem fail to achieve adequate plasma concentrations in ICU patients. Acta Anaesthesiol Scand. 2016;60(10):1425–1436. doi: 10.1111/aas.12808.
   PubMed Web of Science ®Google Scholar
• Campbell PO, Chin PKL, Dalton SC, et al. Frequency of pharmacological target attainment with flucloxacillin and cefazolin in invasive methicillin-susceptible Staphylococcus aureus infection: a prospective cohort study in hospitalized patients. Int J Antimicrob Agents. 2023;61(1):106695. doi: 10.1016/j.ijantimicag.2022.106695.
   PubMed Web of Science ®Google Scholar
• Beumier M, Casu GS, Hites M, et al. Elevated beta-lactam concentrations associated with neurological deterioration in ICU septic patients. Minerva Anestesiol. 2015;81(5):497–506.
   PubMed Web of Science ®Google Scholar
• Imani S, Buscher H, Marriott D, et al. Too much of a good thing: a retrospective study of beta-lactam concentration-toxicity relationships. J Antimicrob Chemother. 2017;72(10):2891–2897. doi: 10.1093/jac/dkx209.
   PubMed Web of Science ®Google Scholar
• Vardakas KZ, Kalimeris GD, Triarides NA, et al. An update on adverse drug reactions related to beta-lactam antibiotics. Expert Opin Drug Saf. 2018;17(5):499–508. doi: 10.1080/14740338.2018.1462334.
   PubMed Web of Science ®Google Scholar
• Venugopalan V, Casaus D, Kainz L, et al. Use of therapeutic drug monitoring to characterize cefepime-related neurotoxicity. Pharmacotherapy. 2023;43(1):6–14. doi: 10.1002/phar.2744.
   PubMed Web of Science ®Google Scholar
• de Vroom SL, van Daalen FV, Zieck SE, et al. Does dose reduction of renally cleared antibiotics in patients with impaired renal function lead to adequate drug exposure? A systematic review. Clin Microbiol Infect. 2021;27(3):352–363. doi: 10.1016/j.cmi.2020.11.032.
   PubMed Web of Science ®Google Scholar
• Camargo MS, Mistro S, Oliveira MG, et al. Association between increased mortality rate and antibiotic dose adjustment in intensive care unit patients with renal impairment. Eur J Clin Pharmacol. 2019;75(1):119–126. doi: 10.1007/s00228-018-2565-7.
   PubMed Web of Science ®Google Scholar